I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Cell Lysis/Cell
Fractionation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 2: World 7-Year Perspective for Cell Lysis/Cell
Fractionation by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 4: World 7-Year Perspective for Consumables by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 5: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 6: World 7-Year Perspective for Instruments by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 7: World Current & Future Analysis for Mammalian Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World 7-Year Perspective for Mammalian Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Microbial Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 10: World 7-Year Perspective for Microbial Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Other Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 12: World 7-Year Perspective for Other Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Research
Laboratories & Institutes by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World 7-Year Perspective for Research Laboratories &
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 15: World Current & Future Analysis for Biopharmaceutical &
Biotechnology Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 16: World 7-Year Perspective for Biopharmaceutical &
Biotechnology Companies by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 17: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 18: World 7-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 19: USA Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 20: USA 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 21: USA Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 22: USA 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 23: USA Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 24: USA 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

CANADA
Table 25: Canada Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 26: Canada 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 27: Canada Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 28: Canada 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 29: Canada Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 30: Canada 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

JAPAN
Table 31: Japan Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 32: Japan 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 33: Japan Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 34: Japan 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 35: Japan Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 36: Japan 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

CHINA
Table 37: China Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: China 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 39: China Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 40: China 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 41: China Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 42: China 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

EUROPE
Table 43: Europe Current & Future Analysis for Cell Lysis/Cell
Fractionation by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 44: Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2020 & 2027

Table 45: Europe Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 46: Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 47: Europe Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 48: Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 49: Europe Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

FRANCE
Table 51: France Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 52: France 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 53: France Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 54: France 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 55: France Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: France 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

GERMANY
Table 57: Germany Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 58: Germany 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 59: Germany Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 60: Germany 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 61: Germany Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: Germany 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

ITALY
Table 63: Italy Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 64: Italy 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 65: Italy Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 66: Italy 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 67: Italy Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Italy 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

UNITED KINGDOM
Table 69: UK Current & Future Analysis for Cell Lysis/Cell
Fractionation by Product Type - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 70: UK 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 71: UK Current & Future Analysis for Cell Lysis/Cell
Fractionation by Type - Mammalian Cells, Microbial Cells and
Other Types - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 72: UK 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 73: UK Current & Future Analysis for Cell Lysis/Cell
Fractionation by End-Use - Research Laboratories & Institutes,
Biopharmaceutical & Biotechnology Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: UK 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

REST OF EUROPE
Table 75: Rest of Europe Current & Future Analysis for Cell
Lysis/Cell Fractionation by Product Type - Consumables and
Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 76: Rest of Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 77: Rest of Europe Current & Future Analysis for Cell
Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial
Cells and Other Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 78: Rest of Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 79: Rest of Europe Current & Future Analysis for Cell
Lysis/Cell Fractionation by End-Use - Research Laboratories &
Institutes, Biopharmaceutical & Biotechnology Companies and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 80: Rest of Europe 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

ASIA-PACIFIC
Table 81: Asia-Pacific Current & Future Analysis for Cell
Lysis/Cell Fractionation by Product Type - Consumables and
Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 82: Asia-Pacific 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 83: Asia-Pacific Current & Future Analysis for Cell
Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial
Cells and Other Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 84: Asia-Pacific 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 85: Asia-Pacific Current & Future Analysis for Cell
Lysis/Cell Fractionation by End-Use - Research Laboratories &
Institutes, Biopharmaceutical & Biotechnology Companies and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 86: Asia-Pacific 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

REST OF WORLD
Table 87: Rest of World Current & Future Analysis for Cell
Lysis/Cell Fractionation by Product Type - Consumables and
Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 88: Rest of World 7-Year Perspective for Cell Lysis/Cell
Fractionation by Product Type - Percentage Breakdown of Value
Sales for Consumables and Instruments for the Years 2020 & 2027

Table 89: Rest of World Current & Future Analysis for Cell
Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial
Cells and Other Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 90: Rest of World 7-Year Perspective for Cell Lysis/Cell
Fractionation by Type - Percentage Breakdown of Value Sales for
Mammalian Cells, Microbial Cells and Other Types for the Years
2020 & 2027

Table 91: Rest of World Current & Future Analysis for Cell
Lysis/Cell Fractionation by End-Use - Research Laboratories &
Institutes, Biopharmaceutical & Biotechnology Companies and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 92: Rest of World 7-Year Perspective for Cell Lysis/Cell
Fractionation by End-Use - Percentage Breakdown of Value Sales
for Research Laboratories & Institutes, Biopharmaceutical &
Biotechnology Companies and Other End-Uses for the Years 2020 &
2027

IV. COMPETITION
Total Companies Profiled: 44